Table 3.

Survival characteristics of hepatocellular carcinoma patients by AFP-L3%

Variable	AFP-L3 (%)
	<10 (n=85)	=10(n=80)	Total
Total AFP 10-200 (ng/ml)
Number of Subjects	15	37	52
Observed Deaths	6	17	23
Expected Deaths	10.44	21.03	31.48
O/E ratio (95% CI)	0.57 (0.21-1.25)	0.81 (0.47-1.29)	0.73 (0.46-1.10)
Total AFP >200 (ng/ml)
Number of Subjects	8	43	51
Observed Deaths	6	36	42
Expected Deaths	3.01	17.10	20.11
O/E ratio (95% CI)	1.99 (0.73-4.33)	2.11 (1.47-2.91)	2.09 (1.50-2.82)
All HCC with AFP =10 (ng/ml)
Number of Subjects	23	80	103
Observed Deaths	12	53	65
Expected Deaths	13.46	38.13	51.59
O/E ratio† (95% CI)	0.89 (0.46-1.56)	1.39 (1.04-1.82)	2.28 (0.97-1.61)
Expected Deaths Adj. AFP	13.74	51.26
O/E ratio (95% CI)	0.9 (0.45-1.53)	1 (0.77-1.35)

* Expected deaths estimated from the number of deaths during follow-up

^† The model chi squares for the analyses stratified by total AFP were not significant, thus the analyses performed were for the combined AFP groups

O/E observed/expected ratio.